RxCap
RxCap is a Boston-based medication adherence technology company providing LTE-connected smart caps, pill organizers, and multidose packaging devices, plus cloud software and APIs, for U.S. pharmacies, health plans, device manufacturers, and life sciences companies.
- Company typePrivate
- Founded2015
- HeadquartersBoston, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What RxCap does
RxCap, Inc. is a Boston-based, privately held medication adherence technology company founded in 2015 that builds proprietary cellular-connected hardware (smart caps that replace standard prescription vial closures, an LTE-based smart weekly pill organizer co-developed with Centor, and a smart multidose packaging device that detects pouch removals and bridges to Bluetooth physiological devices) combined with a cloud software platform, a patient portal, a consumer mobile app (RxCap Adhere), and an open API library for healthcare enterprise integration. The company's core technology differentiator is automatic LTE data transmission that requires no patient-side app pairing or setup, capturing real-time, event-level medication consumption rather than relying on retrospective metrics such as Proportion of Days Covered (PDC). RxCap is certified in the Epic App Orchard, enabling clinicians to launch adherence programs and view real-time data inside the Epic EMR at the point of care, and integrates with OMRON Connect 2.0, FDB Meducation, ZEPHYRx cloud spirometry, and Wysa's behavioral health platform.
RxCap serves four primary customer segments: (1) pharmacies and providers seeking reimbursable Remote Therapeutic Monitoring (RTM) and Remote Patient Monitoring (RPM) programs under CMS CPT codes 98975–98981; (2) health plans and PBMs pursuing improved STAR ratings and reduced hospitalization costs; (3) device manufacturers seeking differentiated connected product offerings; and (4) life sciences companies for clinical trial adherence and post-commercialization patient support. Named enterprise relationships include Yale Medical, UCLA (clinical study NCT03460587 reporting 90.9% adherence in stroke survivors), OMRON Healthcare, First Databank, ZEPHYRx, Medistics, and Wysa.
The business model combines hardware sales (smart caps, pill organizers, multidose packaging), recurring software and API platform subscriptions (including white-label arrangements), exclusive channel distribution through Centor/Gerresheimer for U.S. pharmacies, and customized managed services for enterprise partners. In April 2024, Gerresheimer acquired a minority equity stake in RxCap and secured exclusive U.S. pharmacy distribution rights through its subsidiary Centor, while appointing a director to RxCap's board—signaling strategic validation and a major channel unlock. As of 2024, RxCap had raised approximately $21.16 million across roughly 22 investors via an SEC Form D exempt offering.
RxCap firmographics
Firmographics- Name
- RxCap
- Legal name
- RxCap, Inc.
- Website
- https://rxcap.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- RxCap is a Boston-based medication adherence technology company providing LTE-connected smart caps, pill organizers, and multidose packaging devices, plus cloud software and APIs, for U.S. pharmacies, health plans, device manufacturers, and life sciences companies.
- Ownership category
- akta.pro rank
RxCap industry classification
Industry- Product category
- Medication Adherence Devices
- NAICS
- Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
- akta.pro secondary industries
- Medication Adherence, Reminders & Patient Support (HLACAKAF), Patient App, Adherence & Engagement for RPM Programs (HLACAFAJ), Medication Therapy Management (MTM) & Adherence Programs (HLAEAKAH)
Keywords
Where RxCap is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
RxCap business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Connected Device Sales: Sale of proprietary cellular medication adherence devices including smart caps, pill organizers, and multidose packaging devices. Devices can be white-labeled for partners.
- Software Platform and API Access: Cloud-based software platform for data collection, monitoring, and patient engagement. API access for enterprise integration. Supports reimbursable Remote Therapeutic Monitoring (RTM) services.
- Channel Distribution (Centor/Gerresheimer): Exclusive distribution partnership for U.S. pharmacies through Centor. RxCap provides devices and software, Centor handles pharmacy sales and customer relationships.
- Strategic Partnership Solutions: Customized solutions for enterprise partners including device customization, white-labeling, and integrated remote monitoring programs.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels4 records
RxCap product offering
Product offeringCore offering
RxCap designs, manufactures, and sells proprietary cellular LTE-connected medication adherence hardware (smart caps, weekly pill organizers, and multidose packaging devices) and pairs them with cloud-based software, patient-facing portal and mobile apps, and an API library. The platform enables healthcare enterprises to capture real-time medication adherence events and run reimbursable Remote Therapeutic Monitoring (RTM) and Remote Patient Monitoring (RPM) programs.
Product overview
RxCap is a medication adherence partner offering a modular portfolio of software, APIs, and devices for healthcare enterprises. The product portfolio consists of proprietary adherence monitoring hardware (Cellular Smart Caps, Smart Pill Organizer, Smart Multidose Packaging Device, and Proprietary Data Hubs) combined with patient-facing software (Patient Portal, Mobile Apps including RxCap Adhere) and an API Library for developer integration. The platform enables real-time medication adherence monitoring with cellular devices that transmit data automatically without patient setup, supporting remote therapeutic monitoring and remote patient monitoring programs for pharmacies, health plans, device manufacturers, and life sciences companies.
Differentiator
Problem solved
Functional benefit
Brands
- RxCap Adhere: Patient-facing mobile app for medication adherence tracking with FDB Meducation integration
Products and services
- Cellular Smart Caps Smart caps that attach to standard prescription vials and automatically record and transmit medication adherence data via cellular LTE signals when the vial is opened, designed for healthcare enterprises running remote monitoring and adherence programs.
- Smart Pill Organizer LTE-based weekly pill organizer with LED indicators that automatically captures and transmits real-time medication removal events without requiring patient app installation, available to U.S. pharmacies via Centor (Gerresheimer).
- Smart Multidose Packaging Device Cellular-connected device that automatically tracks when medication pouches are removed from the box and supports all common multidose pouch and sleeve sizes, with optional Bluetooth pairing of physiological devices for additional clinical insight.
- Proprietary Data Hubs Proprietary data collection and transmission hubs that provide secure, zero-friction remote monitoring across RxCap's adherence and integrated physiological devices for healthcare enterprises.
- RxCap Adhere Mobile App Patient-facing mobile app that lets patients import prescribed medications, receive medication reminders, record adherence confirmations, access simplified Meducation instructions, and alert caregivers when doses are missed.
- RxCap API Library Open-architecture API library that enables healthcare enterprises and ecosystem partners to integrate RxCap's adherence and physiological data into their own care management platforms, EHR workflows, and remote monitoring services.
Quantifiable outcome
- 90.9% prescription adherence rate observed in clinical study of stroke survivors using RxCap technology
- +2 more outcomes
Companies that use RxCap
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
RxCap technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability3 records
Feature7 records
RxCap partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and flagship.
- WysacoreWysa, a global leader in AI-driven behavioral health support, announced a strategic partnership with RxCap to bring remote monitoring technology into Wysa's care platform. Through this integration, Wysa's healthcare clients can deploy RxCap's connected adherence devices and cloud-based software directly within their existing care workflows. The collaboration gives provider clients real-time insights into medication adherence to help drive better patient outcomes and more effective care management.
- Centor (Gerresheimer)flagshipCentor Inc., a Gerresheimer company and leading provider of regulatory compliant prescription containers and remote care solutions, co-developed a new LTE-based smart weekly pill organizer with RxCap. The smart pill organizer is now available to U.S. pharmacies through Centor's remote monitoring service. This partnership solidifies Centor's position as a leader in innovative drug containment and medication adherence solutions.
- Gerresheimer / CentorflagshipGerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, partnered with RxCap and acquired a minority stake. Under the terms of the agreement, Gerresheimer's subsidiary Centor receives the exclusive distribution rights for pharmacies in the U.S. for adherence solutions by RxCap, consisting of connected prescription vial closure devices and complementary cloud-based software. Centor is the U.S. market leader in prescription vials and is uniquely positioned to enable smart adherence solutions through existing pharmacy workflows. Gerresheimer will also appoint a representative to RxCap's Board of Directors.
- ZEPHYRxcoreRxCap partnered with ZEPHYRx LLC, a remote respiratory monitoring solutions provider, to integrate the ZEPHYRx cloud spirometry platform with RxCap's remote monitoring platform. With this partnership, RxCap's enterprise customers can monitor the lung function of their patients with serious pulmonary conditions. The combination enables medication adherence data from RxCap's devices combined with real-time pulmonary function test data from ZEPHYRx to improve patient outcomes.
- MedisticscoreMedistics LLC, a New Jersey-based care management company, partnered with RxCap to provide a comprehensive Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) solution. The partnership enables Qualified Health Care Professionals (QHCPs) to offer reimbursable services by utilizing existing RPM/RTM programs for their patients, providing more personalized and proactive care.
- EpiccoreRxCap achieved certification and availability of their prescription adherence platform within the Epic App Orchard. The integration enables doctors and clinicians to access real-time medication adherence data directly within Epic EMR workflows at the point of care, within seconds. Clinicians can also access additional medication handling information like humidity and temperature data through RxCap's portal directly integrated with Epic.
- First Databank (FDB)coreFirst Databank (FDB), the leading provider of drug and medical device knowledge, partnered with RxCap to release a patient-facing mobile app (RxCap Adhere) that allows patients to import personalized medication instructions from FDB Meducation. The app includes medication reminders, adherence confirmation, and access to educational materials written at 5th- to 8th-grade reading level.
- OMRON HealthcarecoreOMRON Healthcare partnered with RxCap to integrate smart medication caps with OMRON Connect 2.0 digital health service. Through the partnership, OMRON Connect 2.0 pairs with RxCap smart medication caps to monitor adherence and set reminders to take specific medications, fostering patient-doctor dialogue and providing personalized insights.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
RxCap competitors and assessment
Company assessmentDirect peers
- AdhereTech: AdhereTech makes connected smart pill bottles that automatically track medication adherence and send real-time reminders, directly overlapping with RxCap's smart cap and adherence device portfolio for pharma and health system customers.
- Medisafe: Medisafe is a digital medication adherence platform combining a patient app, reminders, and analytics for pharma and health plans — directly comparable to RxCap's patient-facing app and adherence analytics stack.
- eTectRx: eTectRx produces the ID-Cap system, a smart cap with embedded ingestible event marker that confirms actual medication ingestion — a close technical peer to RxCap's smart cap adherence technology.
- MedMinder: MedMinder provides connected pill dispensers with cellular connectivity and adherence reminders for pharmacies, patients, and caregivers — competing in the same pharmacy-channel smart adherence category as RxCap.
- Spencer Health Solutions: Spencer Health Solutions offers a connected medication dispensing and adherence platform with integrated RPM, serving pharma, payers, and providers with a comparable hardware-plus-software model to RxCap.
- Hero Health: Hero Health makes a smart pill dispenser with reminders and adherence tracking, competing in the connected medication management space where RxCap's smart pill organizer and multidose devices operate.
Emerging players
- Propeller Health (ResMed): Propeller Health provides connected inhaler sensors and respiratory adherence platforms, overlapping with RxCap's adherence + physiological device integration strategy in chronic respiratory care.
Broad incumbents
- Vivify Health: Vivify Health is an established RPM/RTM platform serving health systems and payers with broader remote care workflows, competing with RxCap on the enterprise RTM billing side.
- Health Recovery Solutions (HRS): HRS provides RPM kits, software, and clinical workflow tools for hospitals and home health agencies, offering a broader RPM alternative to RxCap's adherence-focused platform.
- Caregility: Caregility is a broader virtual care and RPM platform serving health systems, with adjacent adherence and remote monitoring capabilities that overlap RxCap's enterprise RPM/RTM positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
RxCap financial estimates
Financial estimateRevenue estimate
Valuation estimate
RxCap leadership team
Management profileNumber of profiles
Profiles5 records
RxCap funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RxCap M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RxCap
What does RxCap do?
RxCap designs, manufactures, and sells proprietary cellular LTE-connected medication adherence hardware (smart caps, weekly pill organizers, and multidose packaging devices) and pairs them with cloud-based software, patient-facing portal and mobile apps, and an API library. The platform enables healthcare enterprises to capture real-time medication adherence events and run reimbursable Remote Therapeutic Monitoring (RTM) and Remote Patient Monitoring (RPM) programs.
Is RxCap a public or private company?
RxCap is a private company. It is classified as venture growth investor backed and is currently operating.
When was RxCap founded?
RxCap was founded in 2015. It employs 1 to 10 people.
Where is RxCap based?
RxCap is headquartered in Boston, United States, in the North America region.
How does RxCap make money?
Four revenue lines are on record. Connected Device Sales are the primary driver. The others are software Platform and API Access, channel Distribution (Centor/Gerresheimer) and strategic Partnership Solutions.
Who are RxCap's main competitors?
Direct peers on record are AdhereTech, Medisafe, eTectRx, MedMinder, Spencer Health Solutions and Hero Health. Propeller Health (ResMed) is listed as an emerging player. Broad incumbents are Vivify Health, Health Recovery Solutions (HRS) and Caregility.
Does RxCap have an API?
Yes. API library to support wide range of remote monitoring use cases and patient journeys. RxCap provides an open-architecture, full stack solution that enables ecosystem partners to quickly launch efficient remote care services with complete clinical context for medication, biometrics, and physiological data.
What industry is RxCap in?
RxCap's product category is Medication Adherence Devices. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLACAKAF, Medication Adherence, Reminders & Patient Support. Its NAICS code is 541511 and its SIC code is 7372.